DA Davidson Reiterates Neutral Rating for Herbalife (NYSE:HLF)

Herbalife (NYSE:HLF)‘s stock had its “neutral” rating reaffirmed by DA Davidson in a research note issued on Thursday,Benzinga reports. They presently have a $7.50 target price on the stock. DA Davidson’s price target would indicate a potential downside of 9.29% from the company’s previous close.

HLF has been the subject of several other reports. B. Riley lowered their target price on Herbalife from $17.00 to $12.00 and set a “buy” rating for the company in a research report on Thursday, October 31st. Citigroup lowered their price objective on Herbalife from $16.00 to $13.00 and set a “buy” rating for the company in a research report on Friday, October 25th. Mizuho upped their target price on Herbalife from $8.00 to $9.00 and gave the company a “neutral” rating in a report on Friday, November 1st. Finally, StockNews.com upgraded shares of Herbalife from a “hold” rating to a “buy” rating in a report on Monday, November 4th. One analyst has rated the stock with a sell rating, two have assigned a hold rating and three have issued a buy rating to the company. According to MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $9.90.

Herbalife Stock Up 3.1 %

Shares of HLF opened at $8.27 on Thursday. The stock has a market cap of $833.33 million, a PE ratio of 3.32, a PEG ratio of 0.20 and a beta of 1.15. Herbalife has a 12-month low of $5.04 and a 12-month high of $12.79. The business has a 50-day simple moving average of $6.27 and a two-hundred day simple moving average of $7.24.

Herbalife (NYSE:HLF) last issued its quarterly earnings data on Wednesday, February 19th. The company reported $0.36 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.08 by $0.28. Herbalife had a net margin of 5.09% and a negative return on equity of 19.71%. The business had revenue of $1.21 billion during the quarter, compared to analyst estimates of $1.19 billion. On average, equities research analysts expect that Herbalife will post 1.57 EPS for the current year.

Institutional Investors Weigh In On Herbalife

Hedge funds have recently added to or reduced their stakes in the business. Perpetual Ltd grew its position in shares of Herbalife by 107.1% during the 4th quarter. Perpetual Ltd now owns 966,063 shares of the company’s stock worth $6,463,000 after buying an additional 499,572 shares during the period. Barclays PLC grew its holdings in Herbalife by 347.0% in the third quarter. Barclays PLC now owns 161,426 shares of the company’s stock worth $1,160,000 after purchasing an additional 125,311 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its holdings in Herbalife by 72.1% in the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 168,209 shares of the company’s stock worth $1,209,000 after purchasing an additional 70,498 shares during the period. SG Americas Securities LLC increased its stake in Herbalife by 83.5% in the fourth quarter. SG Americas Securities LLC now owns 18,884 shares of the company’s stock valued at $126,000 after purchasing an additional 8,591 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. raised its holdings in shares of Herbalife by 6.9% during the third quarter. Charles Schwab Investment Management Inc. now owns 2,479,957 shares of the company’s stock valued at $17,831,000 after purchasing an additional 160,792 shares during the period.

Herbalife Company Profile

Herbalife Ltd. provides health and wellness products in North America, Mexico, South and Central America, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers products in the areas of weight management; targeted nutrition; energy, sports, and fitness; outer nutrition; and literature and promotional items.